Relitegatide
Relitegatide is a selective αvβ6 integrin-binding peptide. Relitegatide functions as the αvβ6-binding building block of the trimeric PET probe Trivehexin. Relitegatide can be used for research on pancreatic ductal adenocarcinoma (PDAC).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 2708163-13-5
- Formel: C51H75N13O13
- Molecular Weight:1078.22
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
Other In-stock Forms of Relitegatide
-
Biologische Aktivität
-
Chemical Information
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle Radionuclide-Drug Conjugates (RDCs) Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
αvβ6 |
RDC Peptide |
Chemical Information
-
CAS. Nr. 2708163-13-5
-
Molecular Weight 1078.22
-
Formel C51H75N13O13
-
Sequence
c[Tyr-Arg-Gly-Asp-Leu-Ala-Tyr-DPro-(NMe)Lys]
-
Sequence Shortening
c[YRGDLAY-DPro-(NMe)K]
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Quigley NG, et al. PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin. Eur J Nucl Med Mol Imaging. 2022;49(4):1136-1147. [Content Brief]
[2]. Zhang X, et al. Design, Synthesis, and Biological Evaluation of [18F]AlF-Labeled Integrin αvβ6-Targeting Tracers for Pancreatic Cancer Imaging. J Med Chem. 2025 Jul 10;68(13):14028-14040. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Relitegatide Related Classifications
HY-P11708 Related Classifications
Powered by Bioz